Form 483

Oscor Inc. Form 483, 2017-03-23

FDA issued a Form 483 to Oscor Inc. on 2017-03-23 with 21 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health21 observations

Oscor Inc. · Palm Harbor, United States · Issued March 23, 2017

Overview

  • 21 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

23 Mar 2017
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Lisa A Warner, Stanley B Eugene, Kimberly Lewandowski-Walker

23 Mar 2017
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Lisa A Warner, Stanley B Eugene, Kimberly Lewandowski-Walker

23 Mar 2017
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Lisa A Warner, Stanley B Eugene, Kimberly Lewandowski-Walker

23 Mar 2017
21 CFR 820.184

DHR content

Cited by Lisa A Warner, Stanley B Eugene, Kimberly Lewandowski-Walker

23 Mar 2017
21 CFR 820.184

DHR content

Cited by Lisa A Warner, Stanley B Eugene, Kimberly Lewandowski-Walker

Inspected site

OIOscor Inc.Palm Harbor, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 820.100(a)Cited across public-safe Form 483 observations3x
21 CFR 820.184Cited across public-safe Form 483 observations3x
21 CFR 820.198(e)Cited across public-safe Form 483 observations3x
21 CFR 820.30(g)Cited across public-safe Form 483 observations3x
21 CFR 820.70(a)Cited across public-safe Form 483 observations3x
21 CFR 820.70(b)Cited across public-safe Form 483 observations3x
21 CFR 820.75(a)Cited across public-safe Form 483 observations3x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 21 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere